Lilly says 2007 earnings will be less than expected
From Bloomberg News
Eli Lilly & Co. projected a 2007 earnings rise that trailed analysts’ estimates because the planned purchase of Icos Corp., maker of the impotence pill Cialis, would reduce profit more than some analysts expected.
Net income next year will be $3.25 to $3.35 a share, said the Indianapolis-based maker of Zyprexa, the world’s top-selling schizophrenia medicine, at an investor meeting in New York.
Its shares fell 87 cents, or 1.6%, to $53.99.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
